John L Erb
CIK 1213867 · CEO and President · last filed 2025-07-01
John L Erb is a CEO and President who has filed 48 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for NUWE, was dated Jul 1, 2025. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $76.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
VASC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
6464 SYCAMORE COURT N.
MINNEAPOLIS,, MN 55369
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NUWE | CEO and President | 83 | $5.43 | $451 | $0 | 6 | 2025-07-01 |
| Miromatrix Medical Inc. (MIRO) Delisted | Director | 0 | $3.39 | $0 | $50.0K | 6 | 2023-12-13 |
| Nuwellis, Inc. (CHFS) Delisted | Chairman of the Board | 387 | $5.28 | $2.0K | $100.0K | 5 | 2021-01-26 |
| ELMD | Director | 3,000 | $25.30 | $75.9K | $0 | 1 | 2019-12-04 |
| Nuwellis, Inc. (SSH) Delisted | CEO and President | 115,468 | — | — | $0 | 1 | 2017-04-20 |
| VASCULAR SOLUTIONS INC (VASC) Delisted | Director | 12,451 | — | — | -$1.77M | 17 | 2016-05-03 |
| SENORX INC (SENO) Delisted | Director | 10,652 | — | — | $28.5K | 6 | 2010-07-07 |
Recent Filings
48 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-01 | NUWE | Grant (A) | — | $0 | EDGAR |
| 2025-06-11 | NUWE | Mixed | +1,100,022 | $66.0K | EDGAR |
| 2023-12-13 | Miromatrix Medical Inc. (MIRO) Delisted | Mixed | −110,461 | $0 | EDGAR |
| 2023-06-05 | Miromatrix Medical Inc. (MIRO) Delisted | Grant (A) | +54,201 | $0 | EDGAR |
| 2023-05-23 | NUWE | Grant (A) | — | $0 | EDGAR |
| 2023-03-30 | Miromatrix Medical Inc. (MIRO) Delisted | Buy (P) | +31,250 | $50.0K | EDGAR |
| 2022-08-16 | Miromatrix Medical Inc. (MIRO) Delisted | Grant (A) | +12,788 | $0 | EDGAR |
| 2022-05-26 | NUWE | Grant (A) | — | $0 | EDGAR |
| 2021-08-20 | NUWE | Grant (A) | — | $0 | EDGAR |
| 2021-06-29 | Miromatrix Medical Inc. (MIRO) Delisted | Conv (C) | +6,667 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.